InMode Ltd (INMD)
18.01
-0.99
(-5.21%)
USD |
NASDAQ |
Nov 15, 16:00
18.01
0.00 (0.00%)
After-Hours: 04:20
InMode Profit Margin (Quarterly): 39.15% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 39.15% |
| June 30, 2024 | 27.55% |
| March 31, 2024 | 29.52% |
| December 31, 2023 | 43.51% |
| September 30, 2023 | 37.79% |
| June 30, 2023 | 40.95% |
| March 31, 2023 | 38.19% |
| December 31, 2022 | 28.23% |
| September 30, 2022 | 40.24% |
| June 30, 2022 | 38.79% |
| March 31, 2022 | 36.05% |
| December 31, 2021 | 47.66% |
| September 30, 2021 | 47.48% |
| June 30, 2021 | 46.87% |
| Date | Value |
|---|---|
| March 31, 2021 | 40.66% |
| December 31, 2020 | 48.03% |
| September 30, 2020 | 40.02% |
| June 30, 2020 | 27.91% |
| March 31, 2020 | 15.91% |
| December 31, 2019 | 40.50% |
| September 30, 2019 | 40.45% |
| June 30, 2019 | 40.72% |
| March 31, 2019 | 33.14% |
| December 31, 2018 | -0.74% |
| September 30, 2018 | 33.98% |
| June 30, 2018 | 30.26% |
| March 31, 2018 | 30.44% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
15.91%
Minimum
Mar 2020
48.03%
Maximum
Dec 2020
37.75%
Average
39.58%
Median
Profit Margin (Quarterly) Benchmarks
| Compugen Ltd | 7.45% |
| Pluri Inc | -5.97K% |
| BioLine Rx Ltd | 8.97% |
| Can Fite Biofarma Ltd | -1.07K% |
| BiomX Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 20.14% |
| Return on Assets | 18.15% |
| Return on Invested Capital | 20.14% |
| Gross Profit Margin (Quarterly) | 81.53% |
| Operating Margin (Quarterly) | 37.06% |
| Return on Net Operating Assets | 127.6% |